Debt Financing for Life Sciences and Healthcare Companies

Debt financing options for life science and healthcare companies have never been so varied or creative. This event will include a discussion with a panel of experts on the alternatives offered in today’s credit markets. The panelists' conversation will highlight key structural features and performance metrics – what’s market in which market – that affect a company’s ability to access debt financing over the course of its development. Larry Wittenberg and Anna Dodson will provide a welcome and introduction, and Danielle Lauzon will moderate the panel.